Drug Shortage Report for MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

Last updated on 2019-06-19 History
Report ID 47356
Drug Identification Number 02461412
Brand name MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Common or Proper name EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) EFAVIRENZ TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE
Strength(s) 600MG 300MG 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BT
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-06-11
Actual start date
Estimated end date 2019-06-21
Actual end date 2019-06-18
Shortage status Resolved
Updated date 2019-06-19
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v64 2019-06-19 English Compare
v63 2019-06-18 French Compare
v62 2019-06-18 English Compare
v61 2019-06-12 English Compare
v60 2019-06-04 French Compare
v59 2019-06-04 English Compare
v58 2019-05-28 French Compare
v57 2019-05-28 English Compare
v56 2019-05-28 French Compare
v55 2019-05-28 English Compare
v54 2019-05-28 English Compare
v53 2019-05-22 French Compare
v52 2019-05-22 English Compare
v51 2019-05-14 French Compare
v50 2019-05-14 English Compare
v49 2019-04-10 French Compare
v48 2019-04-10 English Compare
v47 2019-04-03 French Compare
v46 2019-04-03 English Compare
v45 2019-03-28 French Compare

Showing 1 to 20 of 64